Ireland’s Kerry Group has acquired US firm Ganeden, a branded technology company focused on probiotics, for an undisclosed amount.

Ganeden, based in Cleveland, Ohio, has more than 135 patents for technologies in the supplement, food, beverage, nutrition and personal care markets. Its products include GanedenBC30, a patented organism which can be found in more than 125 food, drink and animal products.

Ganeden’s current year revenue is approximately US$25m.

Kerry Foods – known for spreads, cheese products and sausages with brands including Richmond, Dairygold and Matthesons –  said the deal would complement its acquisition of natural immune health ingredient business Wellmune in late 2015.

It said Ganeden’s technologies will be extended into wider applications across Kerry’s markets. 

Ganeden was founded in 1997 in San Diego, California, by Sean Farmer, before moving to Ohio in 2000. The company’s name was derived from the Hebrew Gan Eden, meaning Garden of Eden.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Kerry announced the deal today (11 October), alongside new growth targets for the business over the medium term. It is targeting 3% to 5% volume growth annually on a group-wide basis.